Abstract:Background: Stimulation of nitric oxide (NO) synthesis similar to the application of NO donors could be of benefit in liver fibrosis. Many authors believe that activation of NO synthesis by pharmacological agents is promising in the treatment of liver fibrosis. However, there is considerable controversy in understanding the role of NO in fibrogenesis and fibrolysis. The aims of our study were to evaluate the effects of L-arginine, as an NO metabolic precursor, and those of NO synthase (NOS) inhibitors, L-nitroarginine methyl ester (L-NAME) and aminoguanidine (AG) in rats with thioacetamide (TAA)-induced liver fibrosis reversal. Materials and methods: Male Wistar rats, 230-240 g, received TAA (200 mg kg(-1), intraperitoneally) twice a week for 3 months. Liver resolution was simulated by withdrawal of TAA administration. Thereafter the animals were subdivided into five groups and treated by intragastric intubation with: L-arginine (100 and 300 mg kg(-1)); L-NAME as an inhibitor of both constitutively expressed NOS (eNOS) and inducible NOS (iNOS) (20 mg kg(-1)), AG as a specific inhibitor of iNOS (100 mg kg(-1)) or placebo. The severity of liver fibrosis was assessed by morphometric evaluation of liver slides stained with Azan-Mallory, hydroxyproline (Hyp) determination and mRNA steady state levels of collagen I, transforming growth factor (TGF)-beta1, metalloproteinases (MMP)-13, -14, tissue inhibitor of MMP (TIMP)-1 and plasminogen activator inhibitor (PAI)-1 were quantified by real time PCR. The activities of serum marker enzyme, alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase, were measured. Results: TAA treatment during 3 months induced micronodular liver fibrosis with a pronounced deposition of collagen fibres. L-Arginine did not affect this deposition nor did it affect both relative and total liver hydroxyproline content. Both NOS inhibitors significantly increased the square of the liver connective tissue stained by Azan-Mallory and the above parameters characterizing liver hydroxyproline content. Both NOS inhibitors up-regulated procollagen alpha1 (I), MMP-13, TIMP-1 and PAI-1 mRNA expression. The AG effects were more pronounced. than those of L-NAME. AG treatment also increased mRNA expression of TGF-beta1 and PAI-1. Conclusions: Both NOS inhibitors developed a clear pro-fibrotic effect in the liver. Aminoguanidine was more fibrotic than L-NAME. Our data suggest a significant anti-fibrotic role for iNOS rather than for eNOS. L-Arginine did not show any anti-fibrotic properties in the TAA-model used.

Synthesis of N~G-nitro-Arginine-Lysine Tripeptide and Its Inhibition on NOS

Insights into the Substrate Tolerance of Enzymes Involved in the Nosiheptide Biosynthesis Pathway Based on Indolic Acid Moiety

Sodium Nitroprusside Regulates Mrna Expressions of LTC4 Synthesis Enzymes in Hepatic Ischemia/Reperfusion Injury Rats Via NF-κB Signaling Pathway

Synthesis and biological evaluation of 5-nitropyrimidine-2,4-dione analogues as inhibitors of nitric oxide and iNOS activity.

Synthesis and Bioactivities of Nitronyl Nitroxide and RGD Containing Pseudopeptides

Development of novel nitric oxide production inhibitors based on the 7H-pyrrolo[2,3-d]pyrimidine scaffold

Synthesis of a novel series of diphenolic chromone derivatives as inhibitors of NO production in LPS-activated RAW264.7 macrophages.

Progress in inhibitors of nitric oxide synthase

[Molecular Mechanism of Nitric Oxide in Preventing Cardiomyocytes from Hypertrophic Response Induced by Angiotensin II].

Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal

Biphasic Effects of Sodium Nitroprusside on Cell Proliferation and Protein Synthesis in Rat Kidney Slices-Influence of Specific Cyclic Guanylyl Cyclase Inhibitor-ODQ

Synthesis and structure-activity relationships of guaiane-type sesquiterpene lactone derivatives with respect to inhibiting NO production in lipopolysaccharide-induced RAW 264.7 macrophages.

Synthesis and Evaluation of New Α-Methylene-γ-lactone Carbamates with NO Production Inhibitory Effects in Lipopolysaccharide-Induced RAW 264.7 Macrophages.

Synthesis and Evaluation of Alternative Substrates for Arginasease

Synthesis And Biological Activity Of Nitronyl Nitroxide Containing Peptides

Research Progress of Inducible Nitric Oxide Synthase Inhibitors

The Study of Aminoguanidine's Effect on Transmembrane L-arginine Transport and Cationic Amino Acid Transporter.2 Expression of Lipopolysaccharide-Activated RAW264.7 Cells

Development of a Novel Nitric Oxide (NO) Production Inhibitor with Potential Therapeutic Effect on Chronic Inflammation

Nitric Oxide Inhibits the Basolateral 10-Ps Cl - Channels Through Cgmp/pkg 1 Signaling Pathway in the Thick Ascending Limb of C57BL/6 Mice.

Synthesis and inhibition of NO production activities of 1, 6-0, O-diacylbritannilactone derivatives

Specificity of Inducible Nitric-Oxide Synthase Inhibitors: Prospects for Their Clinical Therapy.